BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 10159647)

  • 21. Pharmacists' and physicians' attitudes toward pharmaceutical marketing practices.
    Poirier TI; Giannetti V; Giudici RA
    Am J Hosp Pharm; 1994 Feb; 51(3):378-81. PubMed ID: 8160692
    [No Abstract]   [Full Text] [Related]  

  • 22. A study of interactions between pharmaceutical representatives and ophthalmology trainees.
    Wang Y; Adelman RA
    Am J Ophthalmol; 2009 Oct; 148(4):619-622.e3. PubMed ID: 19570520
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Dangerous liaisons--physicians and pharmaceutical sales representatives].
    Granja M
    Acta Med Port; 2005; 18(1):61-8. PubMed ID: 16202335
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Why lunch matters: assessing physicians' perceptions about industry relationships.
    Fugh-Berman AJ; Scialli AR; Bell AM
    J Contin Educ Health Prof; 2010; 30(3):197-204. PubMed ID: 20872775
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structured approach to pharmaceutical representatives. Family medicine residency program.
    Kelcher S; Brownoff R; Meadows LM
    Can Fam Physician; 1998 May; 44():1053-6, 1059-60. PubMed ID: 9612591
    [TBL] [Abstract][Full Text] [Related]  

  • 26. National survey of recent changes in hospital policies on pharmaceutical sales representatives' activities.
    Thomas J
    Am J Hosp Pharm; 1989 Mar; 46(3):565-9. PubMed ID: 2719042
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Physicians and drug industry: attitudes and practice].
    Aasland OG; Førde R
    Tidsskr Nor Laegeforen; 2004 Oct; 124(20):2603-6. PubMed ID: 15534631
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Psychiatric resident and faculty views on and interactions with the pharmaceutical industry.
    Misra S; Ganzini L; Keepers G
    Acad Psychiatry; 2010; 34(2):102-8. PubMed ID: 20224017
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Attitudes of general practitioners in New Zealand to pharmaceutical representatives.
    Thomson AN; Craig BJ; Barham PM
    Br J Gen Pract; 1994 May; 44(382):220-3. PubMed ID: 8204336
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interactions between physicians and the pharmaceutical industry: what does the literature say?
    Lexchin J
    CMAJ; 1993 Nov; 149(10):1401-7. PubMed ID: 8221424
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A survey of german physicians in private practice about contacts with pharmaceutical sales representatives.
    Lieb K; Brandtönies S
    Dtsch Arztebl Int; 2010 Jun; 107(22):392-8. PubMed ID: 20574555
    [TBL] [Abstract][Full Text] [Related]  

  • 32. What information do physicians receive from pharmaceutical representatives?
    Lexchin J
    Can Fam Physician; 1997 May; 43():941-5. PubMed ID: 9154366
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Attitudes and beliefs regarding direct-to-consumer advertising of pharmaceutical drugs: an exploratory comparison of physicians and pharmaceutical sales representatives.
    Schulz SA; Broekemier GM; Burkink TJ
    Health Mark Q; 2014; 31(3):279-91. PubMed ID: 25120047
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interactions between physicians and the pharmaceutical industry generally and sales representatives specifically and their association with physicians' attitudes and prescribing habits: a systematic review.
    Fickweiler F; Fickweiler W; Urbach E
    BMJ Open; 2017 Sep; 7(9):e016408. PubMed ID: 28963287
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interactions between doctors and pharmaceutical sales representatives.
    Lexchin J
    Can J Clin Pharmacol; 2001; 8(2):64-5. PubMed ID: 11493932
    [No Abstract]   [Full Text] [Related]  

  • 36. The value of pharmaceutical representative visits and medication samples in community-based family practices.
    Backer EL; Lebsack JA; Van Tonder RJ; Crabtree BF
    J Fam Pract; 2000 Sep; 49(9):811-6. PubMed ID: 11032205
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A national survey of physician-industry relationships.
    Campbell EG; Gruen RL; Mountford J; Miller LG; Cleary PD; Blumenthal D
    N Engl J Med; 2007 Apr; 356(17):1742-50. PubMed ID: 17460228
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [An analysis of the pharmaceuticals market in Vietnam].
    Simonet D
    Sante; 2001; 11(3):155-60. PubMed ID: 11641078
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmaceutical representatives' beliefs and practices about their professional practice: a study in Sudan.
    Idris KM; Mustafa AF; Yousif MA
    East Mediterr Health J; 2012 Aug; 18(8):821-6. PubMed ID: 23057370
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Attitudes and behaviors of psychiatry residents and psychiatrists working in training institutes towards the relationship between the pharmaceutical industry and physicians].
    Gülöksüz S; Oral ET; Ulaş H
    Turk Psikiyatri Derg; 2009; 20(3):236-42. PubMed ID: 19757223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.